ConductScience.org, home

Paper39015802

Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1/PD-L1 blockade.

Jin C and 5 others. Mater Today Bio, 2024. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1/PD-L1 blockade. Papers, record 39015802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39015802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1/PD-L1 blockade.
PubMed
Journal
Mater Today Bio
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
2.74, provisional
iCite
Revised in PubMed
2024-07-18
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jin CChengyan
2Zhang YYan
3Li BBaofeng
4Gao TTianci
5Wang BBin
6Hua PPeiyan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136209263Tumor microenvironment and immunotherapy of oral cancer.Eur J Med Res2022https://conductscience.org/library/papers/36209263PubMed
236638189Selective STING stimulation in dendritic cells primes antitumor T cell responses.Sci Immunol2023https://conductscience.org/library/papers/36638189PubMed
337877690A Self-Immolative DNA Nanogel Vaccine toward Cancer Immunotherapy.Nano Lett2023https://conductscience.org/library/papers/37877690PubMed
436604431Neoantigens: promising targets for cancer therapy.Signal Transduct Target Ther2023https://conductscience.org/library/papers/36604431PubMed
535994713Novel Cocktail Therapy Based on a Nanocarrier with an Efficient Transcytosis Property Reverses the Dynamically Deteriorating Tumor Microenvironment for Enhanced Immunotherapy.Nano Lett2022https://conductscience.org/library/papers/35994713PubMed
636322666Multiplexed high-throughput immune cell imaging reveals molecular health-associated phenotypes.Sci Adv2022https://conductscience.org/library/papers/36322666PubMed
733378609Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.N Engl J Med2021https://conductscience.org/library/papers/33378609PubMed
832357402Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A Streptococcus.Nanomaterials (Basel)2020https://conductscience.org/library/papers/32357402PubMed
921900389Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma.Clin Cancer Res2011https://conductscience.org/library/papers/21900389PubMed
1030736848
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.
J Immunother Cancer2019https://conductscience.org/library/papers/30736848PubMed
1135874717Immunotherapy: Reshape the Tumor Immune Microenvironment.Front Immunol2022https://conductscience.org/library/papers/35874717PubMed
1235020204Cancer statistics, 2022.CA Cancer J Clin2022https://conductscience.org/library/papers/35020204PubMed
1334594036Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors.Nat Med2021https://conductscience.org/library/papers/34594036PubMed
1436113330A generally minimalist strategy of constructing biomineralized high-efficiency personalized nanovaccine combined with immune checkpoint blockade for cancer immunotherapy.Biomaterials2022https://conductscience.org/library/papers/36113330PubMed
1537002376The role of macrophages in the tumor microenvironment and tumor metabolism.Semin Immunopathol2023https://conductscience.org/library/papers/37002376PubMed
1637159807Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells.Int J Nanomedicine2023https://conductscience.org/library/papers/37159807PubMed
1725233993mRNA-based therapeutics--developing a new class of drugs.Nat Rev Drug Discov2014https://conductscience.org/library/papers/25233993PubMed
1838516806A polyamino acid-based phosphatidyl polymer library for in vivo mRNA delivery with spleen targeting ability.Mater Horiz2024https://conductscience.org/library/papers/38516806PubMed
1936591226mRNA vaccines for cancer immunotherapy.Front Immunol2022https://conductscience.org/library/papers/36591226PubMed
2038348177Precision USPIO-PEG-SLex Nanotheranostic Agent Targeted Photothermal Therapy for Enhanced Anti-PD-L1 Immunotherapy to Treat Immunotherapy Resistance.Int J Nanomedicine2024https://conductscience.org/library/papers/38348177PubMed

See all 42 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42941797Recent Advances in Lipid Nanoparticles for Cancer Vaccines: From Antigen Delivery to Personalized Immunotherapy.Int J Mol Sci2026https://conductscience.org/library/papers/42941797PubMed
42455409Smart nanoparticle vaccines integrate nanotechnology artificial intelligence and immunoengineering for precision immunization.Discov Nano2026https://conductscience.org/library/papers/42455409PubMed
41677522Nanomaterial-Enabled Modulation of Tumor-Associated Macrophages and Dendritic Cells to Enhance Cancer Immunotherapy.Nanomaterials (Basel)2026https://conductscience.org/library/papers/41677522PubMed
41638631Biomimetic and personalized nanovaccines in cancer immunotherapy: Design innovations, translational challenges, and future directions.J Adv Res2026https://conductscience.org/library/papers/41638631PubMed
41584362Concerns and challenges in clinics-guided nanovaccines design and applications.Acta Pharm Sin B2026https://conductscience.org/library/papers/41584362PubMed
41479883Targeting persistently activated inflammatory microenvironment to promote chronic wound healing.Front Immunol2025https://conductscience.org/library/papers/41479883PubMed
41377933mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics.Cancer Innov2025https://conductscience.org/library/papers/41377933PubMed
41181604Novel strategies for nanovaccine application in breast cancer treatment.Front Pharmacol2025https://conductscience.org/library/papers/41181604PubMed
41080724Lipid nanoparticle-mediated mRNA/siRNA dual-bioengineered dendritic cell vaccines combined of PD-1/PD-L1 blockade for boosting tumor immunotherapy.Mater Today Bio2025https://conductscience.org/library/papers/41080724PubMed
41032607Enhancing mRNA therapy through iterative delivery.Sci Adv2025https://conductscience.org/library/papers/41032607PubMed
41012179Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer.Vaccines (Basel)2025https://conductscience.org/library/papers/41012179PubMed
40709686Developing Biomaterial-Based mRNA Delivery System for Lung Disease Treatment.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40709686PubMed
40573881Synergistic Integration of HDAC Inhibitors and Individualized Neoantigen Therapy (INT): A Next-Generation Combinatorial Approach for Cancer Immunotherapy.Vaccines (Basel)2025https://conductscience.org/library/papers/40573881PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39015802

GET https://conductscience.org/api/papers/v1/39015802/references?page=2